Clinical trial

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With…

NCT00003854 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00003854
Title Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
Official title A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Breast Cancer
Intervention type Other, Procedure, Radiation
Interventions immunohistochemistry staining method, lymphangiography, sentinel lymph node biopsy, therapeutic conventional surgery, whole breast irradiation
Enrollment 4,590
Start date Apr 1, 1999
Primary completion Aug 1, 2006
Completion Jul 1, 2011
First posted Jan 27, 2003
Last update posted Jul 13, 2016
Countries Australia, Ireland, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies